Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Theraclion SAS

www.theraclion.com

Latest From Theraclion SAS

Global Device Approvals Snapshot: April 16-22, 2019

A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. This week, FDA approved BaroNova's TransPyloric Shuttle and its delivery system to treat obesity. It also cleared NeuroSigma’s Monarch external trigeminal nerve stimulation system, making it the first FDA-approved device for treating attention deficit hyperactivity disorder.

Approvals Clinical Trials

Global Device Approvals, Weekly Snapshot: April 9-15, 2018

A snapshot of global medical device and diagnostics approvals recorded during the past week in Medtech Insight's Approvals Tracker.

Approvals Innovation

Theraclion Tries Keytruda-HiFU Combo To Treat Metastatic Breast Cancer

US FDA has approved the University of Virgina's plan to evaluate a therapy combining Theraclion's high intensity focused ultrasound with Merck's Keytruda (pembrolizumab) immunotherapy drug for the treatment of metastatic breast cancer.

Clinical Trials Innovation

Deals Shaping The Medical Industry, May 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Deal-making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in April 2017.

Deals BioPharmaceutical
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Theraclion SAS
  • Senior Management
  • Ismaël Nujurally , MD, CEO
    François Lacoste, CSO
    David Del Bourgo , Dir., Bus. Dev.
  • Contact Info
  • Theraclion SAS
    Phone: (33) 1 53 10 30 90
    29 rue du Faubourg Saint Jacques
    Paris, 75014
    France
UsernamePublicRestriction

Register